CinRx Pharma

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

The past year has seen an increase in investment in biopharma companies following a couple of lean years, but the sector is not fully out of the woods yet. However, most industry leaders see funding

Viking Therapeutics continued producing eye-catching obesity data with its dual GLP-1/GIP agonist VK2735 at the ObesityWeek 2024 meeting in San Antonio, with its oral formulation showing class-leading

Two new venture capital funds based outside of the US together offer $365m for life science start-ups, including Amplitude Ventures’ second fund and XGEN Venture’s inaugural fund. Montreal-based Ampli